Archive

Fountain Report Excerpts May 28, 2024

The updated version of the Combating Illicit Xylazine Act has bipartisan support in Congress, the AVMA reports. The U.S. Drug Enforcement Administration has even taken the unusual step of calling the bill out by name as legislation that should be signed into law. The updated bill would make xylazine a Schedule III drug. It also ensures [...]
Read More

Fountain Report Excerpts May 21, 2024

Main Street Capital Corporation said it has completed a follow-on investment totaling $25.9 million in Nebraska Vet AcquireCo LLC, doing business as Heritage Vet Partners P.C. Main Street completed the follow-on investment in Heritage to support Heritage’s acquisition of Muleshoe Animal Clinic PLLC, Muleshoe Vet Labs LLC and Muleshoe Vet Supply LP. Muleshoe is a [...]
Read More

Fountain Report Excerpts May 14, 2024

Elanco Animal Health reported first quarter revenue of $1.2 billion, down 4%. Pet health segment revenue of $639 million was down 5%, and farm animal segment revenue of $573 million was down 3%. Reported net income of $32 million was down 69%, reported earnings per share of 6 cents were down 71%, and adjusted EBITDA of [...]
Read More

Fountain Report Excerpts May 8, 2024

Zoetis reported first quarter revenue of $2.2 billion, up 10% from last year’s first quarter. Net income for the quarter was $599 million, or $1.31 per diluted share, up 9% and 10% respectively on a reported basis. The company updated its 2024 financial guidance. Zoetis expects revenue in 2024 to be between $9.050 billion and [...]
Read More